tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Viking Therapeutics’ VK2735: A Promising Phase 3 Study for Weight Management
PremiumCompany AnnouncementsViking Therapeutics’ VK2735: A Promising Phase 3 Study for Weight Management
2d ago
Viking Therapeutics’ VK2735 Study: A Potential Game-Changer for Weight Management in Type 2 Diabetes
Premium
Company Announcements
Viking Therapeutics’ VK2735 Study: A Potential Game-Changer for Weight Management in Type 2 Diabetes
2d ago
Viking Therapeutics price target lowered to $75 from $80 at JPMorgan
Premium
The Fly
Viking Therapeutics price target lowered to $75 from $80 at JPMorgan
5d ago
Viking Therapeutics offered ‘transformative’ Q3 update, says Cantor Fitzgerald
PremiumThe FlyViking Therapeutics offered ‘transformative’ Q3 update, says Cantor Fitzgerald
6d ago
Viking Therapeutics Advances Obesity Treatment Pipeline
Premium
Company Announcements
Viking Therapeutics Advances Obesity Treatment Pipeline
7d ago
Viking Therapeutics Gains Buy Rating Amid Promising Obesity Treatment Developments and Strategic Advancements
Premium
Ratings
Viking Therapeutics Gains Buy Rating Amid Promising Obesity Treatment Developments and Strategic Advancements
7d ago
Options Volatility and Implied Earnings Moves This Week, October 20 – October 24, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, October 20 – October 24, 2025
9d ago
Is VKTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is VKTX a Buy, Before Earnings?
10d ago
Viking Therapeutics: Promising Position in GLP-1 Market with Strategic Growth Potential
Premium
Ratings
Viking Therapeutics: Promising Position in GLP-1 Market with Strategic Growth Potential
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100